A clinical trial of a knowledge-based medical record. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


A clinical trial of a knowledge-based medical record.

Medinfo. 1995;8 Pt 2:1076-80. Unique Identifier : AIDSLINE MED/96174193
Safran C; Rind DM; Davis RB; Sands DZ; Caraballo E; Rippel K; Wang Q; Rury C; Makadon HJ; Cotton DJ; et al; Department of Medicine, Beth Israel Hospital, Center for Clinical; Computing, Harvard Medical School, Boston MA, USA.


Abstract: To meet the needs of primary care physicians caring for patients with HIV infection, we developed a knowledge-based medical record to allow the on-line patient record to play an active role in the care process. These programs integrate the on-line patient record, rule-based decision support, and full-text information retrieval into a clinical workstation for the practicing clinician. To determine whether use of a knowledge-based medical record was associated with more rapid and complete adherence to practice guidelines and improved quality of care, we performed a controlled clinical trial among physicians and nurse practitioners caring for 349 patients infected with the human immuno-deficiency virus (HIV); 191 patients were treated by 65 physicians and nurse practitioners assigned to the intervention group, and 158 patients were treated by 61 physicians and nurse practitioners assigned to the control group. During the 18-month study period, the computer generated 303 alerts in the intervention group and 388 in the control group. The median response time of clinicians to these alerts was 11 days in the intervention group and 52 days in the control group (PJJ0.0001, log-rank test). During the study, the computer generated 432 primary care reminders for the intervention group and 360 reminders for the control group. The median response time of clinicians to these alerts was 114 days in the intervention group and more than 500 days in the control group (PJJ0.0001, log-rank test). Of the 191 patients in the intervention group, 67 (35%) had one or more hospitalizations, compared with 70 (44%) of the 158 patients in the control group (PJ=J0.04, Wilcoxon test stratified for initial CD4 count). There was no difference in survival between the intervention and control groups (P = 0.18, log-rank test). We conclude that our clinical workstation significantly changed physicians' behavior in terms of their response to alerts regarding primary care interventions and that these interventions have led to fewer patients with HIV infection being admitted to the hospital.
Keywords: Adult Antiviral Agents/ADMINISTRATION & DOSAGE Attitude of Health Personnel AIDS-Related Opportunistic Infections/DIAGNOSIS/PREVENTION & CONTROL CD4 Lymphocyte Count *Decision Making, Computer-Assisted *Expert Systems Hospital Information Systems Human HIV Infections/*DRUG THERAPY/IMMUNOLOGY/MORTALITY *Medical Records Systems, Computerized Physicians Practice Guidelines Quality of Health Care Reminder Systems Statistics, Nonparametric Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Survival Rate Zidovudine/ADMINISTRATION & DOSAGE CLINICAL TRIAL CONTROLLED CLINICAL TRIAL JOURNAL ARTICLE

KWDadultantiviralagents/administration&dosageattitudeofhealthpersonnelaids-relatedopportunisticinfections/diagnosis/prevention&controlcd4lymphocytecountKWDdecisionmaking,computer-assistedKWDexpertsystemshospitalinformationsystemshumanhivinfections/KWDdrugtherapy/immunology/mortalityKWDmedicalrecordssystems,computerizedphysicianspracticeguidelinesqualityofhealthcareremindersystemsstatistics,nonparametricsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDsurvivalratezidovudine/administration&dosageclinicaltrialcontrolledclinicaltrialjournalarticle
960630
M9660759


Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .